Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Asset Writedowns and Impairment (2021 - 2025)

Rapid Micro Biosystems' Asset Writedowns and Impairment history spans 5 years, with the latest figure at $1.1 million for Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment rose 1083.16% to $1.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.1 million, a 1103.16% increase, with the full-year FY2025 number at $1.1 million, up 1103.16% from a year prior.
  • Asset Writedowns and Impairment hit $1.1 million in Q4 2025 for Rapid Micro Biosystems, up from $19000.0 in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for RPID hit a ceiling of $1.1 million in Q4 2025 and a floor of -$95000.0 in Q3 2024.
  • Historically, Asset Writedowns and Impairment has averaged $135000.0 across 5 years, with a median of $41500.0 in 2022.
  • Biggest five-year swings in Asset Writedowns and Impairment: surged 2733.33% in 2022 and later plummeted 77.65% in 2025.
  • Tracing RPID's Asset Writedowns and Impairment over 5 years: stood at $16000.0 in 2021, then skyrocketed by 568.75% to $107000.0 in 2022, then crashed by 68.22% to $34000.0 in 2023, then soared by 179.41% to $95000.0 in 2024, then surged by 1083.16% to $1.1 million in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for RPID at $1.1 million in Q4 2025, $19000.0 in Q1 2025, and $95000.0 in Q4 2024.